Columbia researchers have discovered how a genetic defect leads to spinal muscular atrophy, a finding that could lead to a new therapy for a disease that affects 1 in 6,000 children.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Neurologist Scott A. Small participated in a Kavli Foundation roundtable on the link between the brain's ability to make new cells and age-related memory loss.
In most cases of ALS, a toxin released by cells that normally nurture neurons in the brain and spinal cord can trigger loss of the nerve cells affected in the disease, report Columbia researchers.
CUMC researchers have identified a gene that appears to play a major role in motor neuron degeneration in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Patients with an unruptured AV) in the brain are four times more likely to have a stroke or die if they have a procedure to eradicate the AVM than if they receive medical management alone,